GH Jul 2024 22.500 put
| Previous close | 1.0500 |
| Open | 1.0500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 22.50 |
| Expiry date | 2024-07-19 |
| Day's range | 1.0500 - 1.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 197 |
- Business Wire
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PALO ALTO, Calif., May 17, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant’s Board of Directors approved the granting of restricted stock units ("RSUs") representing 215,601 shares of its common stock to 94 new non-executive employees and non-qualified stock option awards to purchase an aggregate of 98,076 shares of its common stock to three new non-executive employees with a grant date
Business WireGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
PALO ALTO, Calif., May 16, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from two real-world studies at the 2024 Digestive Disease Week (DDW) meeting in Washington, DC, highlighting the value of the company’s Shield™ test in colorectal cancer (CRC) screening.
Insider MonkeyGuardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript
Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call Transcript May 10, 2024 Guardant Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and thank you for attending the Guardant Health Q1 2024 Earnings Call. My name is […]
